Antimicrobial Agents and Chemotherapy
View all AAC RSS
- June 11, 2013Ex Vivo Responses of Plasmodium falciparum Clinical Isolates to Conventional and New Antimalarial Drugs in Niger [Epidemiology and Surveillance]
- June 11, 2013Consequences of whiB7 (Rv3197A) Mutations in Beijing Genotype Isolates of the Mycobacterium tuberculosis Complex [Letters]
- June 11, 2013SatR Is a Repressor of Fluoroquinolone Efflux Pump SatAB [Mechanisms of Resistance]
- June 11, 2013Low Rate of Macrolide Resistance in Mycoplasma pneumoniae Strains in Germany between 2009 and 2012 [Letters]
- June 11, 2013Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-{beta}-Lactamase-Producing Escherichia coli [Clinical Therapeutics]
- June 11, 2013Emergence of Extended-Spectrum-{beta}-Lactamase CTX-M-2-Producing Salmonella enterica Serovars Schwarzengrund and Agona in Poultry Farms [Letters]
- June 11, 2013Antimicrobial Susceptibility of Propionibacterium acnes Isolates from Shoulder Surgery [Susceptibility]
- June 11, 2013First Report of a Nonmetallocarbapenemase Class A Carbapenemase in an Enterobacter cloacae Isolate from Colombia [Letters]
- June 11, 2013Molecular Characterization of blaNDM-1 in a Sequence Type 235 Pseudomonas aeruginosa Isolate from France [Mechanisms of Resistance]
- June 11, 2013Genomewide Screen for Modulators of Evolvability under Toxic Antibiotic Exposure [Mechanisms of Resistance]
- June 11, 2013Transition Metal-{alpha}-Amino Acid Complexes with Antibiotic Activity against Mycobacterium spp. [Susceptibility]
- June 11, 2013Relationship of In Vitro Synergy and Treatment Outcome with Daptomycin plus Rifampin in Patients with Invasive Methicillin-Resistant Staphylococcus aureus Infections [Pharmacology]
- June 11, 2013Characterization of pKP1433, a Novel KPC-2-Encoding Plasmid from Klebsiella pneumoniae Sequence Type 340 [Mechanisms of Resistance]
- June 11, 2013Can Intermittent Dosing Optimize Prolonged Linezolid Treatment of Difficult Multidrug-Resistant Tuberculosis? [Clinical Therapeutics]
- June 11, 2013Steady-State Pharmacokinetics of Oral Voriconazole and Its Primary Metabolite, N-Oxide Voriconazole, Pre- and Post-Autologous Peripheral Stem Cell Transplantation [Pharmacology]
- June 11, 2013Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam [Pharmacology]
- June 11, 2013Efficacy of Proveblue (Methylene Blue) in an Experimental Cerebral Malaria Murine Model [Experimental Therapeutics]
- June 11, 2013Determination of Voriconazole Serum Concentration by Bioassay, a Valid Method for Therapeutic Drug Monitoring for Clinical Laboratories [Analytical Procedures]
- June 11, 2013The Clinical Isolate Pseudomonas aeruginosa MMA83 Carries Two Copies of the blaNDM-1 Gene in a Novel Genetic Context [Mechanisms of Resistance]
- June 11, 2013BLIP-II Is a Highly Potent Inhibitor of Klebsiella pneumoniae Carbapenemase (KPC-2) [Mechanisms of Resistance]